Francine Durocher

Biography

Francine Durocher is a Full Professor at the Department of Molecular  Medicine, Laval University, since 2010. Dr Francine Durocher obtained  her PhD at Laval University in 1996. After the completion of her thesis  on BRCA1, she did a first postdoctoral fellow in molecular genetics at  the Hospital for Sick Children, in Toronto, and then completed a second  postdoctoral fellow at the University of Cambridge, England, in genetic  epidemiology and statistics. She was the first Canadian to receive the  Hitchings-Elion Fellowship from the Burroughs Wellcome Fund US. After  the completion of her second postdoc, she started her career at Laval  University in 2001, holding a Research Career Award from the Health  Research Fundation or CIHR. She was the leader of a principal component  of the INHERIT BRCAs CIHR Team grant program from 2001-2006, and is now a  major co-investigator in the CIHR Team on Familial Risks of Breast  Cancer. She has received major operating grants from the Canadian  Institutes of Health Research CIHR and the Canadian Breast Cancer  Research Alliance CBCRA as well as from the Canadian Cancer society  Research Institute CCSRI. Her main research program aims at identifying  novel breast cancer susceptibility loci/genes and is addressed to  high-risk breast cancer families in which no mutation in either of the  two main susceptibility genes, namely BRCA1 or BRCA2, has been  identified. Dr Durocher is also involved in numerous international  consortia, the objectives of which are aiming to identify uncommon or  rare intermediate-risk genetic variants and determine their relative  contribution to the familial relative risk of breast cancer. Francine Durocher is a Full Professor at the Department of Molecular  Medicine, Laval University, since 2010. Dr Francine Durocher obtained  her PhD at Laval University in 1996. After the completion of her thesis  on BRCA1, she did a first postdoctoral fellow in molecular genetics at  the Hospital for Sick Children, in Toronto, and then completed a second  postdoctoral fellow at the University of Cambridge, England, in genetic  epidemiology and statistics. She was the first Canadian to receive the  Hitchings-Elion Fellowship from the Burroughs Wellcome Fund US. After  the completion of her second postdoc, she started her career at Laval  University in 2001, holding a Research Career Award from the Health  Research Fundation or CIHR. She was the leader of a principal component  of the INHERIT BRCAs CIHR Team grant program from 2001-2006, and is now a  major co-investigator in the CIHR Team on Familial Risks of Breast  Cancer. She has received major operating grants from the Canadian  Institutes of Health Research CIHR and the Canadian Breast Cancer  Research Alliance CBCRA as well as from the Canadian Cancer society  Research Institute CCSRI. Her main research program aims at identifying  novel breast cancer susceptibility loci/genes and is addressed to  high-risk breast cancer families in which no mutation in either of the  two main susceptibility genes, namely BRCA1 or BRCA2, has been  identified. Dr Durocher is also involved in numerous international  consortia, the objectives of which are aiming to identify uncommon or  rare intermediate-risk genetic variants and determine their relative  contribution to the familial relative risk of breast cancer.

Research Interest

Her main research program aims at identifying novel breast cancer  susceptibility loci or genes and is addressed to high-risk breast cancer  families in which no mutation in either of the two main susceptibility  genes namely BRCA1 or BRCA2  has been identified. Dr Durocher is also  involved in numerous international consortia, the objectives of which  are aiming to identify uncommon or rare intermediate-risk genetic  variants and determine their relative contribution to the familial  relative risk of breast cancer.